If you'd like your company to be on this list please contact us
Select a name to see a detailed description, expert analysis and contact information.
|"INO announced the publication of data from a preclinical study of the company's plasmid DNA-encoded monoclonal antibody to protect against influenza infections."|
|"Early completion of enrollment for PERSIST, at 12% higher enrollment than targeted, has positive implications for DRRX's Posimir."|